Abstract:
본 발명은 우수한 살모넬라 생장 억제효과를 갖는 신규의 미생물인 락토바실러스 부시네리( Lactobacillus buchneri ) NLRI 1201(KACC 91084) 및 이의 용도에 관한 것이다. 본 발명의 락토바실러스 부시네리 NLRI 1201(KACC 91084)은 항생제인 엠피실린 10㎍/㎖에 상당한 살모넬라 성장 억제 효과를 가지므로, 항생제 대체물질로서 사용될 수 있고, 아울러, 생균제로 대표적으로 사용되는 유산균의 일종이므로, 생균제로 사용될 수 있다.
Abstract:
본 발명은 보리 사일리지 발효용 미생물 첨가제에 관한 것으로, 품질이 우수한 보리 사일리지 추출액을 아지드화나트륨이 함유된 엠알에스(MRS) 액체배지에 넣어 적절히 배양한 후, 백금이를 이용하여 한천평판배지에 도말하고, 다시 배양하여 형성된 균락을 분리하여 얻는다. 상기 본 발명의 미생물 첨가제는 품질이 우수한 보리 사일리지에서 젖산균을 수집 분리하고 산생성 능력이 우수한 균주를 선발하여 첨가제로 개발함으로써, 가축의 조사료(粗飼料)로 이용되는 보리의 사일리지 조제시 첨가하게 되면, 사일리지의 품질을 개선하고 저장성을 향상시킬 수 있는 효과가 있다.
Abstract:
PURPOSE: A microorganism Lactobacillus fermentum and a method for producing conjugated linoleic acid(CLA) using the same microorganism are provided, which microorganism can be used in food because the microorganism is isolated from human, and which conjugated linoleic acid(CLA) has anticancer activity, antioxidative activity, cholesterol reduction, immunity improvement, fat reduction and muscle improvement. CONSTITUTION: The microorganism Lactobacillus fermentum(KACC 91008) is isolated from the feces of human and produces conjugated linoleic acid(CLA), The method for producing conjugated linoleic acid(CLA) comprises the steps of: culturing Lactobacillus fermentum in a medium for 24 hours; adding linoleic acid and tween 80 into the medium; and culturing the medium for 24 hours, thereby the medium contains 0.30 to 0.39 mg of CLA.
Abstract:
PURPOSE: A process of preparing egg white protein hydrolysate improved in flavoring by hydrolyzing egg white protein with protease is provided. Whereby, the product is not decomposed in the body by angiotensin converting enzyme while having excellent inhibitory activity on angiotensin converting enzyme, has excellent antihypertensive properties, is convenient to eat and can be used as a protein supply source. CONSTITUTION: A protease is added to an aqueous egg white protein solution in the amount of 0.1 to 5% and reacts at 30 to 50deg.C and a pH of 6 to 9 for 4 to 48hr. The protease is one or more selected from the group consisting of Protamex(derived from Bacillus), MP(Aspergillus melleus), LP(Aspergillus oryzae), Flavourzyme(Aspergillus oryzae), neutrase, alcalase, Bacillus licheniformis, Promod 192(derived from Aspergillus). For example, egg white is dissolved in water at 55 to 60deg.C, cooled and added with 1% Protamex at a pH of 7. Then the solution reacts at 47deg.C for 28hr and is maintained at 90deg.C for 15min to inactivate enzyme.
Abstract:
The present invention provides a fermented milk composition containing hydrolysate of gelatin and a production method thereof. As the drawings and charts of the present invention, the fermented milk composition containing the hydrolysate of gelatin has a remarkably improved effect on the bone health especially the proliferation of osteoblast, and the weight and mineral content increase of thighbones. Through said effects, the fermented milk composition promotes the growth of children, and prevents osteoporosis of users of old age or women. [Reference numerals] (AA) Increased bone strength(g/mm^2); (BB) Control group; (CC) Process group 1; (DD) Process group 2; (EE) Process group 3
Abstract:
본 발명은 가금분변에서 분리한 항생제저항성 포도상구균과 살모넬라를 억제하는 신규 유산균 락토바실러스 살리바리우스에 관한 것이다. 본 발명에 따른 균주를 이용하면 항생제 대체물질로서 병원균으로 가축 또는 축산식품을 통해 사람에게 전파되지 않도록 제어할 수 있으며, 생균제(Probiotics) 및 건강기능성식품 소재 등 다양한 분야에 이용할 수 있는 장점이 있다.
Abstract:
PURPOSE: Novel lactic acid bacteria, Lactobacillus salivarius, which suppress antibiotic resistant Staphylococcus and Salmonella isolated from poultry excreta is provided to prevent pathogens from being infected to humans through livestock or livestock food products, and to be used in various fields such as probiotics and health functional foods. CONSTITUTION: Lactobacillus salivarius (deposit number: KACC 91656) has 16 rRNA of sequence number 1. The strain suppresses antibiotic resistant Staphylococcus and Salmonella. Probiotics contain the strain. A method for identifying a strain which suppresses antibiotic resistant Staphylococcus and Salmonella isolated from poultry excreta comprises the steps of: collecting the poultry excreta; isolating strains; checking the activity of antibiotics in the isolated strains; and identifying base sequences of the isolated strains. [Reference numerals] (AA) Collect poultry excreta and isolate lactic acid bacteria; (BB) Isolate lactic acid bacteria which excellently suppress antibiotic resistant Staphylococcus; (CC) Isolate lactic acid bacteria which excellently suppress salmonella; (DD) Isolate antibacterial materials and confirm an antibacterial effect; (EE) Identify strains; (FF) Confirm novelty